Travere Therapeutics, Inc. (TVTX)
66.17
-1.34
(-1.98%)
USD |
NASDAQ |
Sep 11, 16:00
66.16
-0.01
(-0.02%)
After-Hours: 20:00
Travere Therapeutics Price : 66.17 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 67.76 | 68.73 | 66.11 | 66.17 | 1.150M |
| Sep 10, 2026 | 65.60 | 68.59 | 64.45 | 67.51 | 1.560M |
| Sep 09, 2026 | 65.80 | 68.23 | 65.59 | 66.22 | 1.236M |
| Sep 08, 2026 | 63.86 | 66.54 | 63.48 | 66.07 | 1.361M |
| Sep 04, 2026 | 66.04 | 67.10 | 65.04 | 65.28 | 1.051M |
| Sep 03, 2026 | 67.18 | 68.03 | 66.04 | 66.54 | 1.115M |
| Sep 02, 2026 | 66.37 | 67.82 | 65.76 | 67.23 | 1.086M |
| Sep 01, 2026 | 66.00 | 66.60 | 65.37 | 65.71 | 1.075M |
| Aug 31, 2026 | 65.70 | 66.70 | 65.07 | 66.28 | 1.891M |
| Aug 28, 2026 | 67.27 | 67.45 | 65.37 | 65.67 | 808519.0 |
| Aug 27, 2026 | 66.69 | 67.85 | 65.65 | 67.52 | 911637.0 |
| Aug 26, 2026 | 66.91 | 67.50 | 65.22 | 67.12 | 1.215M |
| Aug 25, 2026 | 65.74 | 67.34 | 65.74 | 67.01 | 1.507M |
| Aug 24, 2026 | 65.78 | 65.80 | 63.71 | 65.22 | 1.035M |
| Aug 21, 2026 | 64.78 | 66.38 | 64.50 | 65.71 | 1.625M |
| Aug 20, 2026 | 64.82 | 65.54 | 64.02 | 64.46 | 1.067M |
| Aug 19, 2026 | 65.00 | 66.19 | 63.34 | 65.96 | 1.522M |
| Aug 18, 2026 | 62.87 | 64.00 | 62.50 | 63.90 | 884907.0 |
| Aug 17, 2026 | 62.15 | 64.38 | 61.62 | 63.53 | 1.566M |
| Aug 14, 2026 | 60.76 | 62.48 | 60.47 | 62.14 | 1.191M |
| Aug 13, 2026 | 63.33 | 63.33 | 61.06 | 61.43 | 1.285M |
| Aug 12, 2026 | 61.34 | 62.32 | 60.40 | 62.16 | 1.041M |
| Aug 11, 2026 | 60.75 | 61.97 | 60.20 | 60.21 | 1.283M |
| Aug 10, 2026 | 60.56 | 62.57 | 60.56 | 60.89 | 1.765M |
| Aug 07, 2026 | 63.53 | 63.71 | 60.67 | 61.32 | 1.227M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| TG Therapeutics, Inc. | 53.89 |
| Krystal Biotech, Inc. | 347.00 |
| RenovoRx, Inc. | 1.76 |
| Pelthos Therapeutics, Inc. | 21.90 |
| ACADIA Pharmaceuticals, Inc. | 27.83 |
Price Related Metrics
| PS Ratio | 10.58 |
| Price to Book Value | 254.12 |
| Price to Free Cash Flow | 406.35 |
| Earnings Yield | -1.15% |
| Market Cap | 6.232B |